An Evidence-Based Approach to the Evaluation and Treatment Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Tonsillopharyngitis - Acute (1 of 10)
Tonsillopharyngitis - Acute (1 of 10) 1 Patient presents w/ sore throat 2 EVALUATION Yes EXPERT Are there signs of REFERRAL complication? No 3 4 EVALUATION Is Group A Beta-hemolytic Yes DIAGNOSIS Streptococcus (GABHS) • Rapid antigen detection test infection suspected? (RADT) • roat culture No TREATMENT EVALUATION No A Supportive management Is GABHS confi rmed? B Pharmacological therapy (Non-GABHS) Yes 5 TREATMENT A EVALUATE RESPONSEMIMS Supportive management TO THERAPY C Pharmacological therapy • Antibiotics Poor/No Good D Surgery, if recurrent or complicated response response REASSESS PATIENT COMPLETE THERAPY & REVIEW THE DIAGNOSIS© Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B269 © MIMS Pediatrics 2020 Tonsillopharyngitis - Acute (2 of 10) 1 ACUTE TONSILLOPHARYNGITIS • Infl ammation of the tonsils & pharynx • Etiologies include bacterial (group A β-hemolytic streptococcus, Haemophilus infl uenzae, Fusobacterium sp, etc) & viral (infl uenza, adenovirus, coronavirus, rhinovirus, etc) pathogens • Sore throat is the most common presenting symptom in older children TONSILLOPHARYNGITIS 2 EVALUATION FOR COMPLICATIONS • Patients w/ sore throat may have deep neck infections including epiglottitis, peritonsillar or retropharyngeal abscess • Examine for signs of upper airway obstruction Signs & Symptoms of Sore roat w/ Complications • Trismus • Inability to swallow liquids • Increased salivation or drooling • Peritonsillar edema • Deviation of uvula -
Rapid Antigen Detection Test for Group a Streptococcus in Children with Pharyngitis (Review)
Cochrane Database of Systematic Reviews Rapid antigen detection test for group A streptococcus in children with pharyngitis (Review) Cohen JF, Bertille N, Cohen R, Chalumeau M Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD010502. DOI: 10.1002/14651858.CD010502.pub2. www.cochranelibrary.com Rapid antigen detection test for group A streptococcus in children with pharyngitis (Review) Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . ..... 3 BACKGROUND .................................... 5 OBJECTIVES ..................................... 7 METHODS ...................................... 7 RESULTS....................................... 10 Figure1. ..................................... 11 Figure2. ..................................... 12 Figure3. ..................................... 13 Figure4. ..................................... 15 Figure5. ..................................... 16 Figure6. ..................................... 18 Figure7. ..................................... 20 DISCUSSION ..................................... 21 AUTHORS’CONCLUSIONS . 23 ACKNOWLEDGEMENTS . 23 REFERENCES ..................................... 24 CHARACTERISTICSOFSTUDIES . 42 DATA ....................................... -
(12) Patent Application Publication (10) Pub. No.: US 2011/0136210 A1 Benjamin Et Al
US 2011013621 OA1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0136210 A1 Benjamin et al. (43) Pub. Date: Jun. 9, 2011 (54) USE OF METHYLSULFONYLMETHANE Publication Classification (MSM) TO MODULATE MICROBIAL ACTIVITY (51) Int. Cl. CI2N 7/06 (2006.01) (75) Inventors: Rodney L. Benjamin, Camas, WA CI2N I/38 (2006.01) (US); Jeffrey Varelman, Moyie (52) U.S. Cl. ......................................... 435/238; 435/244 Springs, ID (US); Anthony L. (57) ABSTRACT Keller, Ashland, OR (US) Disclosed herein are methods of use of methylsulfonyl (73) Assignee: Biogenic Innovations, LLC methane (MSM) to modulate microbial activity, such as to enhance or inhibit the activity of microorganisms. In one (21) Appl. No.: 13/029,001 example, MSM (such as about 0.5% to 5% MSM) is used to enhance fermentation efficiency. Such as to enhance fermen (22) Filed: Feb. 16, 2011 tation efficiency associated with the production of beer, cider, wine, a biofuel, dairy product or any combination thereof. Related U.S. Application Data Also disclosed are in vitro methods for enhancing the growth of one or more probiotic microorganisms and methods of (63) Continuation of application No. PCT/US2010/ enhancing growth of a microorganism in a diagnostic test 054845, filed on Oct. 29, 2010. sample. Methods of inhibiting microbial activity are also disclosed. In one particular example, a method of inhibiting (60) Provisional application No. 61/294,437, filed on Jan. microbial activity includes selecting a medium that is suscep 12, 2010, provisional application No. 61/259,098, tible to H1N1 influenza contamination; and contacting the filed on Nov. -
Swedres-Svarm 2019
2019 SWEDRES|SVARM Sales of antibiotics and occurrence of antibiotic resistance in Sweden 2 SWEDRES |SVARM 2019 A report on Swedish Antibiotic Sales and Resistance in Human Medicine (Swedres) and Swedish Veterinary Antibiotic Resistance Monitoring (Svarm) Published by: Public Health Agency of Sweden and National Veterinary Institute Editors: Olov Aspevall and Vendela Wiener, Public Health Agency of Sweden Oskar Nilsson and Märit Pringle, National Veterinary Institute Addresses: The Public Health Agency of Sweden Solna. SE-171 82 Solna, Sweden Östersund. Box 505, SE-831 26 Östersund, Sweden Phone: +46 (0) 10 205 20 00 Fax: +46 (0) 8 32 83 30 E-mail: [email protected] www.folkhalsomyndigheten.se National Veterinary Institute SE-751 89 Uppsala, Sweden Phone: +46 (0) 18 67 40 00 Fax: +46 (0) 18 30 91 62 E-mail: [email protected] www.sva.se Text, tables and figures may be cited and reprinted only with reference to this report. Images, photographs and illustrations are protected by copyright. Suggested citation: Swedres-Svarm 2019. Sales of antibiotics and occurrence of resistance in Sweden. Solna/Uppsala ISSN1650-6332 ISSN 1650-6332 Article no. 19088 This title and previous Swedres and Svarm reports are available for downloading at www.folkhalsomyndigheten.se/ Scan the QR code to open Swedres-Svarm 2019 as a pdf in publicerat-material/ or at www.sva.se/swedres-svarm/ your mobile device, for reading and sharing. Use the camera in you’re mobile device or download a free Layout: Dsign Grafisk Form, Helen Eriksson AB QR code reader such as i-nigma in the App Store for Apple Print: Taberg Media Group, Taberg 2020 devices or in Google Play. -
Do Routine Eye Exams Reduce Occurrence of Blindness from Type 2
JFP_09.04_CI_finalREV 8/25/04 2:22 PM Page 732 Clinical Inquiries F ROM T HE F AMILY P RACTICE I NQUIRIES N ETWORK Do routine eye exams reduce photography. Median follow-up was 3.5 years occurrence of blindness (range, 1–8.5 years). from type 2 diabetes? The patients were divided into cohorts based on level of demonstrated retinopathy. The mean screening interval for a 95% probability of remaining free of sight-threatening retinopathy ■ EVIDENCE-BASED ANSWER was calculated for each grade of baseline Screening eye exams for patients with type 2 retinopathy. Screening patients with no retino- diabetes can detect retinopathy early enough so pathy every 5 years provided a 95% probability of treatment can prevent vision loss. Patients with- remaining free of sight-threatening retinopathy. out diabetic retinopathy who are systematically Patients with background retinopathy must be screened by mydriatic retinal photography have a screened annually to achieve the same result, and 95% probability of remaining free of sight-threat- patients with mild preproliferative retinopathy ening retinopathy over the next 5 years. If back- need to be screened every 4 months (Table). ground or preproliferative retinopathy is found at A systematic review2 of multiple small English- screening (Figure), the 95% probability interval language studies evaluating screening and moni- for remaining free of sight-threatening retino- toring of diabetic retinopathy found consistent pathy is reduced to 12 and 4 months, respective- results. Screening by direct or indirect ophthal- ly (strength of recommendation [SOR]: B, based moscopy alone detected 65% of patients with on 1 prospective cohort study). -
Streptococcal Pharyngitis (Strep Throat)
Streptococcal Pharyngitis (Strep Throat) Maria Pitaro, MD ore throat is a very common reason for a visit to a health care provider. While the major treatable pathogen is group A beta hemolytic Streptococcus (GAS), Sthis organism is responsible for only 15-30% of sore throat cases in children and 5-10% of cases in adults. Other pathogens that cause sore throat are viruses (about 50%), other bacteria (including Group C beta hemolytic Streptococci and Neisseria gonorrhea), Chlamydia, and Mycoplasma. In this era of increasing microbiologic resistance to antibiotics, the public health goal of all clinicians should be to avoid the inappropriate use of antibiotics and to target treatment to patients most likely to have infection due to GAS. Clinical Manifestations and chest and in the folds of the skin and usually Pharyngitis due to GAS varies in severity. The spares the face, palms, and soles. Flushing of the Streptococcal Pharyngitis most common presentation is an acute illness with cheeks and pallor around the mouth is common, (Strep Throat). sore throat, fever (often >101°F/38.3°C), tonsillar and the tongue becomes swollen, red, and mottled Inflammation of the exudates (pus on the tonsils), and tender cervical (“strawberry tongue”). Both skin and tongue may oropharynx with adenopathy (swollen glands). Patients may also have peel during recovery. petechiae, or small headache, malaise, and anorexia. Additional physical Pharyngitis due to GAS is usually a self-limited red spots, on the soft palate. examination findings may include petechiae of the condition with symptoms resolving in 2-5 days even Photo courtesy soft palate and a red, swollen uvula. -
Sore Throat in Primary Care Project
Family Practice, 2015, Vol. 32, No. 3, 263–268 doi:10.1093/fampra/cmv015 Advance Access publication 25 March 2015 Epidemiology Sore throat in primary care project: a clinical score to diagnose viral sore throat Selcuk Mistika,*, Selma Gokahmetoglub, Elcin Balcic, and Fahri A Onukd Downloaded from https://academic.oup.com/fampra/article-abstract/32/3/263/695324 by guest on 31 July 2019 aDepartment of Family Medicine, bDepartment of Microbiology, cDepartment of Public Health, Erciyes University Medical Faculty, Kayseri, Turkey, and dBunyamin Somyurek Family Medicine Centre, Kayseri, Turkey. *Correspondence to Prof. S. Mistik, Department of Family Medicine, Erciyes University Medical Faculty, Kayseri 38039, Turkey; E-mail: [email protected] Abstract Objective. Viral agents cause the majority of sore throats. However, there is not currently a score to diagnose viral sore throat. The aims of this study were (i) to find the rate of bacterial and viral causes, (ii) to show the seasonal variations and (iii) to form a new scoring system to diagnose viral sore throat. Methods. A throat culture for group A beta haemolytic streptococci (GABHS) and a nasopharyngeal swab to detect 16 respiratory viruses were obtained from each patient. Over a period of 52 weeks, a total of 624 throat cultures and polymerase chain reaction analyses were performed. Logistic regression analysis was performed to find the clinical score. Results. Viral infection was found in 277 patients (44.3%), and GABHS infection was found in 116 patients (18.5%). An infectious cause was found in 356 patients (57.1%). Rhinovirus was the most commonly detected infectious agent overall (highest in November, 34.5%), and the highest GABHS rate was in November (32.7%). -
No Disclosures
3/15/2017 Cases in Infectious Diseases NO DISCLOSURES Richard A. Jacobs, M.D., PhD. Case Records of the Massachusetts General Hospital Case Presentation A 22 yr old comes to the office complaining of the acute onset of unilateral weakness • Periventricular heterotopia due to an FLNA of the right side of his face. mutation and congenital alveolar dysplasia. Your diagnosis is Bell’s Palsy. N Engl J Med 2017; 376:562‐574 1 3/15/2017 What is Your Therapy? Etiology of Facial Nerve Palsy 100% • 50% are idiopathic (Bell’s Palsy) 1. Prednisolone • Herpes Simplex/Varicella Zoster (Geniculate 2. Acyclovir ganglion) – Direct invasion v. immunologic/inflammatory 3. Prednisolone + • Lyme disease (most common cause of bilateral FN acyclovir palsy) 4. Nothing • Other infections—CMV, EBV,HIV • Non‐infectious—Diabetes, sarcoid, tumors, 1 trauma Therapy of Bell’s Palsy Therapy of Bell’s Palsy • 839 patients enrolled within 72 hours of • Quite controversial onset of symptoms • Because of the association with herpes viruses – Placebo + placebo (206) the use of acyclovir has been felt to be – Prednisilone (60mg X 5 days then reduced beneficial by 10 mg/day) + placebo (210) • – Valacyclovir (1000mg TID X 7 Days) + Two well done prospective, randomized, placebo (207) controlled, blinded studies have been done – Valacyclovir X7 Days + prednisolone X10 Days (206) Lancet Neurol 2008;7:993‐1000 2 3/15/2017 Therapy of Bell’s Palsy Prednisilone Prednisilone • Case closed on therapy??? NO!! + valacyclovir Placebo • Other less powered studies and subgroup Valacyclovir analyses suggest that acyclovir might be + placebo beneficial in the most severe cases – Minimal or no movement of facial muscles and inability to close the eye Take Home Points Case Presentation • 57 yo male with polycystic kidney disease, • Early treatment (within 72 hours of gout, HTN and hyperlipidemia onset) recommended • Underwent bilateral nephrectomies and renal • For most cases prednisolone for 10 days transplant (CMV D +/R‐). -
Supplemental Content Evaluating Different Strategies for Outpatient
Supplemental Content Evaluating different strategies for outpatient antimicrobial surveillance Daniel J Livorsi, MD, MSc; Carrie Linn, PharmD, MPH; Bruce Alexander, PharmD; Brett Heintz, PharmD; Traviss Tubbs, PharmD; Eli Perencevich, MD, MS Supplemental Table 1. Diagnostic categories applied to cohort 1 Supplemental Table 2. ICD-10 codes used to identify cases for manual chart review for cohort 2 Supplemental Figures 1-9. Standardized protocols used to assess antimicrobial necessity Supplemental Figure 10. Rates of antimicrobial overtreatment for 6 infectious syndromes in both the Emergency Department and primary care clinics at the Iowa City VA Medical Center Supplemental Table 1. Diagnostic categories applied to cohort 1 Broad category Specific infectious syndromes Acute respiratory tract infections (ARTIs) Acute Bronchitis Influenza Pertussis Pneumonia Upper respiratory tract infection Ear, nose, and throat (ENT) infections Epiglottitis Laryngitis, acute Mastoiditis Otitis externa Otitis media Parotitis, acute bacterial Peri-tonsillar abscess Pharyngitis Tonsillitis Rhinosinusitis, acute or chronic Exacerbations of COPD or asthma Asthma with acute exacerbation COPD with acute exacerbation Gastroenteritis Gastroenteritis, infectious Clostridium difficile-associated diarrhea Genitourinary (GU) Female-specific infections • Bacterial vaginosis • Bartholin’s cyst, infected • Pelvic inflammatory disease • Trichomoniasis • Vulvovaginal candidiasis Male-specific infections • Balanitis • Epididymitis/orchitis • Prostatitis • Urethritis Sexually-transmitted -
Strep Throat -- Familydoctor.Org
Strep Throat What is strep throat? What are the signs of strep throat? Strep throat is an infection caused by bacteria. It is called "strep" because the bacteria that causes the infection is called streptococcus. Adults with strep throat may have a sore throat, a fever and swollen neck glands. They usually don’t have a cough or a runny nose. Children with strep throat have a sore throat and may have tummy pain or a red rash with small spots. The rash is worse under the arms and in skin creases. How is strep throat treated? Your doctor may give you or your child an antibiotic. Antibiotics kill bacteria, which helps strep throat go away a little faster. It can also prevent a few rare but serious conditions that people with strep throat might get. It is important to take all of the medicine your doctor gives you. Should all sore throats be treated with antibiotics? No. Not every sore throat is strep throat. Bacteria only cause about 5% to 10% of sore throats. The rest are caused by viruses or other problems, and antibiotics will not help. Your doctor can do a test to make sure it is strep throat. What tests can tell I have strep throat? Your doctor may use a test called the rapid strep test. For this test, the doctor uses a long cotton swab to take some material from the back of your throat. The results of this test can be ready in about 15 minutes. Your doctor may also do a culture of the throat material. -
Infectious Disease Control Guideline
Infectious Disease Control Guideline Government of Nepal Ministry of Health and Population Department of Health Services Epidemiology and Disease Control Division 2073 BS (2016 AD) Infectious Disease Control Guideline Contributors Dr. Baburam Marasini, EDCD Dr. Basudev Pandey, LCD Dr. Guna Nidhi Sharma, EDCD Dr. Ram Raj Panthi, EDCD Mr. Bhim Prasad Sapkota, EDCD Mr. Resham Lal Lamichhane, EDCD Clinical Experts Prof. Dr. Buddha Basnyat, PAHS/OUCRU Prof. Dr. Subesh Raj Kayastha, NAMS Prof. Dr. Sudhamshu KC, NAMS Prof. Dr. Shital Adhikari, CMC Dr. Jitendra Man Shrestha Dr. Vivek Kattel, BPKIHS Dr. Anup Bastola, STIDM Technical Support Mr. Pranaya Kumar Upadhyaya, MOH Dr. Prakash Ghimire, WHO Dr. Keshav Kumar Yogi, WHO Dr. Vivek Dhungana, WHO Dr. Neeta Pokhrel Regmi, WHO Preface Table of Contents Contents Page No. Preface ........................................................................................................................................................... 3 Table of Contents .......................................................................................................................................... 4 Acronyms ....................................................................................................................................................... 7 Chapter I: Introduction .................................................................................................................................. 9 1. Background ....................................................................................................................................... -
Infectious Mononucleosis with Staphylococcus Aureus Pharyngitis Co-Infection
Osteopathic Family Physician (2010) 2, 14-17 Infectious mononucleosis with Staphylococcus aureus pharyngitis co-infection Chad E. Richmond, DO, Mark W. Beyer, OMS IV, BS, Bucky A. Ferozan, OMS IV, BS, Christopher Zipp, DO, MS From the Department of Family Medicine, University of Medicine and Dentistry, Stratford, NJ. KEYWORDS: Summary Epstein-Barr virus (EBV), a member of the herpesvirus family, is one of the most common Infectious human viruses affecting more than 90% of the world’s population. The most common manifestation of mononucleosis; primary infection is a self-limited clinical syndrome that most frequently affects adolescents and young Staphylococcus aureus adults. The incidence of clinical infectious mononucleosis is not well documented because reporting is pharyngitis not obligatory in most states. The available data have been derived from special surveys such as the community survey in Olmstead County, Minnesota, which includes the Mayo Clinic, where a rate of 200 per 100,000 patients had a positive heterophile test.1 Once a diagnosis of mononucleosis is confirmed, treatment is supportive because there is no specific treatment for the disease. Mononucleosis is rarely fatal but some complications include central nervous system involvement, splenic rupture, upper airway obstruction, and bacterial super infections. The following clinical case is of a patient diagnosed with acute infectious mononucleosis with Staphylococcus aureus pharyngitis co-infection. © 2010 Elsevier Inc. All rights reserved. Case presentation Focused physical examination The patient had posterior pharyngeal erythema and exu- History of present illness dates with enlarged tonsils. Enlarged posterior and anterior cervical lymph nodes were also noted. The abdomen was D.D., an 18-year-old female dance student in Philadel- soft with minor nonlocalized tenderness on palpation.